Cancer Cytogenomics Microarray Consortium (CCMC) Company Profile

16:38 EDT 20th September 2018 | BioPortfolio

The Cancer Cytogenomics Microarray Consortium (CCMC) was formed in August 2009 by a group of clinical cytogeneticists, molecular geneticists, and molecular pathologists who are interested in applying microarray technologies to cancer diagnosis and cancer research.
The mission of the consortium is to promote communication and collaboration among cancer cytogenomics laboratories. Our goals are to: (1) establish platform-neutral and cancer specific microarray designs for diagnostic purposes, (2) foster collaboration between participating institutions (3), create a public cancer array database and, (4) carry out multi-center cancer translational research. This will ultimately better serve cancer patients and advance the field of cancer genomics.

The CCMC has more than 300 members from over 150 organizations in the U.S., Canada, and abroad.


University of Rochester Medical Center
601 Elmwood Ave, Rochester,


Phone: (585) 275-1077
Fax: (585) 273-3360

News Articles [2019 Associated News Articles listed on BioPortfolio]

C-Path receives COA qualification from FDA for the non-small cell lung cancer SAQ

(Critical Path Institute (C-Path)) Critical Path Institute's (C-Path) Patient-Reported Outcome (PRO) Consortium announces its second clinical outcome assessment (COA) qualification from the US Food an...

Immunovia: diagnosing pancreatic cancer from one drop of blood

Mats Grahn, CEO of Immunovia, discusses the future potential for their Antibody Microarray Technology platform for the early detection of pancreatic cancer.

Affymetrix GeneChip 3000 7G Scanner w/ Autoloader Microarray Genetics DNA

$3,272.95End Date: Saturday Mar-31-2018 7:30:36 PDTBuy It Now for only: $3,272.95Buy It Now | Add to watch list Biotech365 : Affymetrix GeneChip 3000 7G Scanner w/ Autoloader Microarray Genetics ...

Affymetrix GeneChip 3000 7G Scanner w/ Autoloader Microarray DNA Genetics

$2,895.95End Date: Saturday Mar-31-2018 7:30:35 PDTBuy It Now for only: $2,895.95Buy It Now | Add to watch list Biotech365 : Affymetrix GeneChip 3000 7G Scanner w/ Autoloader Microarray DNA Genet...

Consortium launches for development of QSP immune-oncology simulator

A consortium has been launched by Certara for the development of a quantitative systems pharmacology immune-oncology simulator to test combination cancer therapies and different dose regimens and biom...

Beat Childhood Cancer Consortium expands into Canada

(Spectrum Health) Helen DeVos Children's Hospital's consortium, known as Beat Childhood Cancer (BCC), announced today that through a partnership with The C17 Council, the organization's first Canadian...

Optimizing MS care -- Mission of the consortium of multiple sclerosis centers

(Consortium of MS Centers) March is MS Awareness Month and the Consortium of Multiple Sclerosis (CMSC) has partnered with leading organizations, accredited content providers, and its membership to pro...

Affymetrix Genechip 3000 7G Microarray Scanner Autoloader Fluidics 400/450

EUR 8.107,50Einddatum: maandag apr-30-2018 15:20:54 CESTNu kopen voor slechts: EUR 8.107,50Nu kopen | Toevoegen aan volglijst Biotech365 : Affymetrix Genechip 3000 7G Microarray Scanner Autoloade...

PubMed Articles [6386 Associated PubMed Articles listed on BioPortfolio]

Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium.

Aspirin use is associated with reduced risk of several cancers. A pooled analysis of 12 case-control studies showed a 10% decrease in ovarian cancer risk with regular aspirin use, which was stronger f...

No association between circulating concentrations of vitamin D and risk of lung cancer: An analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3).

There is observational evidence suggesting that high vitamin D concentrations may protect against lung cancer. To investigate this hypothesis in detail, we measured circulating vitamin D concentration...

Vertebrate Genome Evolution in the Light of Fish Cytogenomics and rDNAomics.

To understand the cytogenomic evolution of vertebrates, we must first unravel the complex genomes of fishes, which were the first vertebrates to evolve and were ancestors to all other vertebrates. We ...

HPV infection and breast cancer. Results of a microarray approach.

Human papilloma virus (HPV) has been implicated in several types of epithelial cancer. The role of HPV in breast carcinogenesis has been a matter of debate fueled by conflicting reports in recent year...

Consortium Outlines 3 Solutions to Maximize the Benefit and Affordability of Targeted Cancer Drugs.

Clinical Trials [8623 Associated Clinical Trials listed on BioPortfolio]

DNA Microarray Study of Pancreas Cancer

Pancreas cancer and precancerous cysts can be difficult to diagnose. Sometimes biopsies do not show cancer when cancer is actually present. We hypothesize that genetic differences exist in...

Linkage Consortium for End-Stage Renal Disease

The Family Investigation of Nephropathy and Diabetes (FIND)Study is a multi-center consortium. The charge of the consortium is to acquire sets of families with well-characterized diabetic ...

Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique

This is an experimental study of participants who had positive blood culture to compare time to appropriate antibiotic between using Microarray Assay and Mass Spectrometry to bacterial Ide...

Study of Sperm Molecular Factors Implicated in Male Fertility

Sperm analysis following World Health Organization guidelines is unable to explain the molecular causes of male infertility when basic sperm parameters are within a normal range and women ...

Lynne Cohen Consortium Project: Multi-Center Database/Registry

Goals of this registry: 1.1 To collect and store very limited demographic information (age, birthdate, race and ethnicity), limited cancer risk and breast and ovarian disease history, as ...

Companies [1647 Associated Companies listed on BioPortfolio]

Cancer Cytogenomics Microarray Consortium (CCMC)

The Cancer Cytogenomics Microarray Consortium (CCMC) was formed in August 2009 by a group of clinical cytogeneticists, molecular geneticists, and molecular pathologists who are interested in applyin...

WIN Consortium

The WIN Consortium ( is a joint initiative of Institut Gustave Roussy (France) and University of Texas - MD Anderson Cancer Center (USA) which brings togethe...

DNA Microarray (Genome Chip)

Welcome to the DNA Microarray (Genome Chip) Web site! This simple, printer-friendly site has been created and maintained by Leming Shi, Ph.D. You'll find the basics on DNA microarray technology and a ...

Industrial Internet Consortium

The Industrial Internet Consortium® is an open membership organization with over 200 members from 26 countries, formed to accelerate the development, adoption, and wide-spread ...

Cancer Information Service Research Consortium

More Information about "Cancer Cytogenomics Microarray Consortium (CCMC)" on BioPortfolio

We have published hundreds of Cancer Cytogenomics Microarray Consortium (CCMC) news stories on BioPortfolio along with dozens of Cancer Cytogenomics Microarray Consortium (CCMC) Clinical Trials and PubMed Articles about Cancer Cytogenomics Microarray Consortium (CCMC) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cancer Cytogenomics Microarray Consortium (CCMC) Companies in our database. You can also find out about relevant Cancer Cytogenomics Microarray Consortium (CCMC) Drugs and Medications on this site too.

Quick Search


Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Corporate Database Quicklinks

Searches Linking to this Company Record